Summary
- Current Price
- As of today, DMAC price is $8.79, down -5.79% on
- Current Price All-Time High
- DMAC price is currently -80.44% below its historical high of $44.94 set on
- Market Cap
- DMAC current market cap is $474M, up +68.03% over the past 365 days
- Revenue
- DMAC current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DMAC is on
Profile
| Metric | Value |
|---|---|
| Full Name | DiaMedica Therapeutics Inc. |
| Ticker | NASDAQ: DMAC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | diamedica.com |
| Employees | 27 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $8.79 | ||
| Price, 1D Change | -5.79% | |
| $474M | ||
| - | ||
| - | ||
| 1.81 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$0.70 | ||
| EPS, 1Y Change | -15.27% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.70 | ||
| EPS Estimate | - | |
| EPS Est. Change | - | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $8.79 | ||
| Price Target | $13.00 | - |
| Price Tgt. Change | +47.90% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.60 | - | |
| - | -$0.61 | - | |
| - | -$0.70 | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | $0.00 | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +62.18% | ||
| +275.64% | ||
| +68.03% | ||
| +434.04% | ||
| 0.00% | ||
| 0.00% | ||
| -15.27% | ||
| -34.84% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $8.79 | ||
| $7.17 | ||
| $8.21 | ||
| $7.33 | ||
| $8.43 | ||
| $0.35 | ||
| 1.81 | ||
| $0.68 | ||
| 48.25 | ||
| 111.30% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$0.70 | ||
| -$43.00K | ||
| - | ||
| -$34.40M | ||
| - | ||
| -$32.77M | ||
| - | ||
| -$34.35M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 11.81 | ||
| 11.81 | ||
| - | ||
| - | ||
| 49.40 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 16.55 | ||
| -10.52 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $56.11M | ||
| $59.89M | ||
| $61.37M | ||
| $60.63M | ||
| $5.26M | ||
| $5.13M | ||
| $240.00K | ||
| $112.00K | ||
| $1.48M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $32.77M | ||
| $34.35M | ||
| $43.00K | ||
| $0.00 | ||
| $43.00K | ||
| $0.00 | ||
| $28.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$29.46M | ||
| -$2.19M | ||
| $44.28M | ||
| $40.00K | ||
| -$29.50M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | → | |
| Lake Street | → | |
| HC Wainwright & Co. | → | |
| Craig-Hallum | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with DMAC
FAQ
- What is the ticker symbol for DiaMedica Therapeutics Inc.?
- The ticker symbol for DiaMedica Therapeutics Inc. is NASDAQ:DMAC
- Does DiaMedica Therapeutics Inc. pay dividends?
- No, DiaMedica Therapeutics Inc. does not pay dividends
- What sector is DiaMedica Therapeutics Inc. in?
- DiaMedica Therapeutics Inc. is in the Healthcare sector
- What industry is DiaMedica Therapeutics Inc. in?
- DiaMedica Therapeutics Inc. is in the Biotechnology industry
- What country is DiaMedica Therapeutics Inc. based in?
- DiaMedica Therapeutics Inc. is headquartered in United States
- When did DiaMedica Therapeutics Inc. go public?
- DiaMedica Therapeutics Inc. initial public offering (IPO) was on August 3, 2012
- Is DiaMedica Therapeutics Inc. in the S&P 500?
- No, DiaMedica Therapeutics Inc. is not included in the S&P 500 index
- Is DiaMedica Therapeutics Inc. in the NASDAQ 100?
- No, DiaMedica Therapeutics Inc. is not included in the NASDAQ 100 index
- Is DiaMedica Therapeutics Inc. in the Dow Jones?
- No, DiaMedica Therapeutics Inc. is not included in the Dow Jones index
- When was DiaMedica Therapeutics Inc. last earnings report?
- DiaMedica Therapeutics Inc.'s most recent earnings report was on November 12, 2026
- When does DiaMedica Therapeutics Inc. report earnings?
- The next expected earnings date for DiaMedica Therapeutics Inc. is March 30, 2027
Data Sources & References
- DMAC Official Website www.diamedica.com
- DMAC Profile on Yahoo Finance finance.yahoo.com/quote/DMAC
- DMAC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dmac
